Home > Healthcare > Medical Services > Diagnostic Services > HbA1c Testing Market

HbA1c Testing Market Share

Report ID: GMI9631
Published Date: May 2024
Report Format: PDF

Download Free Sample

HbA1c Testing Market Share

The global market for HbA1c testing is highly competitive, driven by technological innovation, increased emphasis on personalized and preventive healthcare, and a rising global diabetes burden. These companies invest heavily in research and development to enhance their product portfolios, expand their market reach, and gain a competitive edge. The competitive scenario in the market is dynamic and characterized by continuous innovation, strategic partnerships, and a focus on delivering value to customers while meeting regulatory requirements and quality standards.

HbA1c Testing Market Companies

Some of the eminent market participants operating in the HbA1c testing industry include:

Abbott Laboratories
ARKRAY, Inc.
Bio-Rad Laboratories, Inc.
Ceragem Medisys Inc.
Danaher Corporation
EKF Diagnostics
F. Hoffmann-La Roche Ltd.
HUMAN
Menarini Diagnostics s.r.l
PTS Diagnostics
Randox Laboratories Ltd.
SAKAE CO. LTD.
SEKISUI MEDICAL CO., LTD.
Siemens Healthineers AG
Trinity Biotech plc

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Market size for HbA1c testing was valued at USD 2.3 billion in 2023 and is estimated to grow at 8.6% CAGR from 2024 to 2032 due to factors, such as the increasing prevalence of diabetes and technological advancements, alongside the development of novel testing methodologies.

The point-of-care (POC) testing segment of the HbA1c testing market is forecasted to reach USD 3.5 billion by 2032 due to the increasing demand for accessible diabetes management, advancements in testing technology, and personalized healthcare.

The immunoassays segment of the HbA1c testing industry accounted for USD 817.1 million in 2023 due to rising diabetes prevalence, technological advancements, and the demand for efficient point-of-care solutions.

Abbott Laboratories, ARKRAY, Inc., Bio-Rad Laboratories, Inc., Ceragem Medisys Inc., Danaher Corporation, EKF Diagnostics, F. Hoffmann-La Roche Ltd., HUMAN, Menarini Diagnostics s.r.l, and PTS Diagnostics, among others.